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Abstract
Type 3 von Willebrand disease (VWD) is a severe hemorrhagic defect in humans. We now
identify the homozygous mutation in the Chapel Hill strain of canine type 3 VWD that results in
premature termination of von Willebrand factor (VWF) protein synthesis. We cultured
endothelium from VWD and normal dogs to study intracellular VWF trafficking and Weibel-
Palade body formation. Weibel-Palade bodies could not be identified in the canine VWD aortic
endothelial cells (VWD-AECs) by P-selectin, VWFpp, or VWF immunostaining and confocal
microscopy. We demonstrate the reestablishment of Weibel-Palade bodies that recruit endogenous
P-selectin by expressing wild-type VWF in VWD-AECs. Expression of mutant VWF proteins
confirmed that VWF multimerization is not necessary for Weibel-Palade body creation. Although
the VWF propeptide is required for the formation of Weibel-Palade bodies, it cannot
independently induce the formation of the granule. These VWF-null endothelial cells provide a
unique opportunity to examine the biogenesis of Weibel-Palade bodies in endothelium from a
canine model of type 3 VWD.
Introduction
von Willebrand factor (VWF) is a large, multimeric glycoprotein that mediates platelet
adhesion to subendothelial tissue at the site of vascular injury. VWF is also the carrier
protein for coagulation factor VIII (FVIII).1,2 Defects in VWF function or decreased levels
of VWF cause von Willebrand disease (VWD).3,4 VWF is synthe sized as pre–pro-VWF
consisting of a 22–amino acid (aa) signal peptide, 741-aa propeptide, and 2050-aa mature
VWF monomer.5-9 VWF undergoes extensive intracellular modification.10 The pro-VWF
forms carboxy-terminal dimers in the endoplasmic reticulum where signal peptide is
removed. The VWF molecule is glycosylated, carbohydrate processed, and sulfated.11,12 In
the Golgi, VWF dimers form amino-terminal multimers, and propeptide is cleaved,
presumably by the enzyme furin.13 VWF is stored together with its propeptide in regulated
secretory vesicles, Weibel-Palade bodies in endothelial cells and α-granules in
megakaryocytes or platelets.6
The VWF released from Weibel-Palade bodies consists of very high-molecular-weight VWF
multimers that are the most active for binding to subendothelial tissue and in platelet-platelet
interactions.14-16 Thus, the multimerization and regulated storage of VWF are important for
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initiation of clot formation following injury to a vessel. The large propeptide, VWFpp, is
required for multimerization and regulated storage of VWF.17,18 Previous studies in our
laboratory have demonstrated that VWF is sorted to regulated storage vesicles in a VWFpp-
dependent manner.19,20 Our studies were carried out using the mouse pituitary model cell
line AtT-20 and bovine aortic endothelial cells (BAECs) that have endogenous-regulated
storage granules containing adrenocorticotrophic hormone (ACTH) or bovine VWF,
respectively. We have demonstrated that the propeptide independently sorts to endogenous
storage granules in these cells and co-traffics mature VWF multimers through a noncovalent
association.19,21 However, because of the presence of endogenous-regulated secretory
vesicles, these studies could not address the biogenesis of the regulated storage vesicle.
Although the biogenesis and exocytosis of Weibel-Palade bodies has been the subject of
investigation, the mechanisms are not well defined.14,22,23 To pursue our studies on
intracellular VWF trafficking and Weibel-Palade body biogenesis, we cultured endothelium
from the Chapel Hill strain of canine (K9) type 3 VWD. Type 3 VWD is a severe bleeding
disorder in humans, characterized by a complete absence of VWF.3 Natural animal models
of type 3 VWD exist in pigs and dogs, as well as a VWF-null transgenic mouse model.24,25
The type 3 VWD dogs have been maintained in Chapel Hill for many years, but the
molecular defect causing the disease had not been identified.26 Here we first identify the
mutation in these dogs that results in premature termination of VWF protein synthesis.
Endothelial cells were obtained from the aortas of VWD dogs, and the absence of Weibel-
Palade bodies, VWFpp, and VWF were confirmed. We have examined the ability of
expressed wild-type and mutant VWF, or VWFpp, to generate storage granules that recruit
endogenous P-selectin to reestablish Weibel-Palade bodies in the VWD endothelial cells.
The availability of a VWF-null, nontransformed endothelial cell has thus provided a




Anti-VWF antibodies 280.1, AVW-1, AVW-5, and 105.4 and the polyclonal, Edwina, were
produced by our laboratory. A rabbit polyclonal anti-human VWF was purchased from Dako
(Carpinteria, CA). The monoclonals AVW-5 and 105.4 and the polyclonal antibodies
recognize both human and canine VWF. The antibody 280.1 is specific for canine VWF and
AVW-1 is human VWF specific. Anti-VWFpp monoclonal antibodies 239.1 to 239.11,
242.4, 242.5, 275.1, and 275.2 were also produced by our laboratory; 239.1, 239.7, 239.8,
239.11, 242.4, and 242.5 recognize canine VWFpp in addition to human, while the 275.1
and 275.2 only recognize canine propeptide. The anti-human platelet endothelial cell
adhesion molecule (PECAM) antibody, PECAM 1.3, was also produced in our laboratory.
Other antibodies used include rabbit polyclonal anti–P-selectin (BD Bioscience, San Jose,
CA), and goat–anti-C3 (Sigma Chemical, St. Louis, MO). Nonimmune mouse and rabbit
immunoglobulin G (IgG) were purchased from Jackson Immunoresearch (West Grove, PA)
and used as isotype controls. Secondary antibodies used for immunofluorescence detection
included goat anti-rabbit and anti-mouse IgG (H+L) [F(Ab’)2] fragments conjugated with
either AlexaFluor-488 or AlexaFluor-568 (Molecular Probes, Eugene, OR), or donkey anti-
rabbit, anti-goat, or anti-mouse IgG (H+L) [F(Ab’)2] fragments (Jackson Immunoresearch)
conjugated with Texas Red (TXR), Red-X, or fluorescein isothiocyanate (FITC).
Constructs
The human and canine VWF, VWF propeptide (VWFpp), and propeptide-deleted VWF
(Δpro) expression vectors were constructed as previously described.21 Briefly, VWFpp
Haberichter et al. Page 2













expression vectors contain signal peptide and VWFpp sequence followed by a stop codon
with the VWF sequence deleted. The Δpro expression vectors contain signal peptide
followed directly by mature VWF sequence. The Y87S-VWF is a full-length VWF construct
that encodes a point mutation in the D1 domain of the VWF propeptide as previously
described.27 VWFpp*C3α vector expresses VWF signal peptide and VWFpp with a
disrupted furin cleavage site followed directly by the α-chain of human complement C3 as
previously described.19
Sequencing
White blood cell DNA was purified from normal and VWD dogs from the colony
maintained at the University of North Carolina, Chapel Hill. In particular, a segment of
genomic sequence spanning from base 228 in exon 4 to base 532 in exon 5 of the VWF gene
was amplified by polymerase chain reaction (PCR) using sense primer K9-VWF s228 to 250
(5′-C CAA AAT GGC AAA AGA GTG AGC C-3′) and antisense primer K9-VWF a532 to
510 (5′-C TTC TTG AGT CCT GAA GTC ATC C-3′). Directly sequencing the PCR
product from 2 VWD dogs using the same antisense primer yielded a single sequence with a
nucleotide deletion of the cytosine at base 255 (ΔC255) of normal canine VWF cDNA. The
PCR products were cloned and sequenced in both directions to confirm the mutation.
Cell culture and transfections
Endothelial cells were harvested by digestion with 1 mg/mL collagenase from the aortas
obtained from normal and VWD dogs. The harvested canine aortic endothelial cells (AECs)
were cultured in Medium 199 (Mediatech, Holy Hill, FL) supplemented with 10% fetal
bovine serum (FBS) and grown on tissue culture dishes coated with 2% gelatin, at 37°C in
an atmosphere of 5% CO2. Cells were transiently transfected by Nucleofection (Amaxa,
Cologne, Germany) according to manufacturer’s instructions. Negative controls were either
nontransfected or mock transfected with expression vector lacking the insert. When
transfected cells reached confluency (3-7 days after nucleofection), conditioned media were
harvested from the cells, centrifuged to remove debris, and frozen at −80°C for further
analysis. Washed cells were either fixed for intracellular staining or used for secretion
studies. To assess stimulated release of expressed VWF proteins, cells were washed with
Hanks balanced salt solution (HBSS), followed by OptiMEM washes, and then incubated
for 30 minutes with either 2 μM phorbol myristate acetate (PMA) or OptiMEM (control).
Releasates were harvested, and secreted VWF protein was quantitated by either VWFpp or
VWF enzyme-linked immunosorbent assay (ELISA).
Confocal immunofluorescence microscopy
Cells were analyzed for the intracellular location of VWF, VWFpp, and other proteins by
immunofluorescence using antibody staining and confocal laser scanning microscopy in the
Imaging Core of the Medical College of Wisconsin using a Leica (Heidelberg, Germany)
TCS SP2 confocal laser imaging system and software with 63 × or 100 × objective lenses as
previously described.20 Cells were grown on 2-well chamber slides coated with 0.2% gelatin
and cross-linked with 0.5% glutaraldehyde. Confluent cells were fixed using 3.7% (vol/vol)
buffered formalin, permeabilized in 1% Triton X-100, and blocked with 2% normal goat
serum or donkey serum in HBSS. Cells were incubated at 4°C overnight in primary
antibodies diluted in HBSS containing 1% bovine serum albumin (BSA). The concentration
of primary antibody varied from 2 to 5 μg/mL. Cells were then washed 3 times with HBSS.
All immunostaining experiments used normal mouse and rabbit IgG for isotype controls.
Cells were incubated in secondary antibodies diluted 1:1000 in HBSS containing 1% BSA
for 30 minutes at room temperature. Cells were then washed 3 times with HBSS and
mounted with cover glass using Vectashield (Vector Labs, Burlingame, CA).
Haberichter et al. Page 3














VWF in the conditioned medium of transfected endothelial cells was analyzed by
electrophoresis through a 0.8% (wt/vol) HGT(P) agarose (FMC Bioproducts, Rockland,
ME) stacking gel and 2% (wt/vol) HGT(P) agarose running gel containing 0.1% sodium
dodecyl sulfate (SDS) for 16 hours at 40 V using the Laemmli buffer system with transfer
and Western blotting as previously described.21 Submarine-agarose gel electrophoresis was
performed as previously described.27
Results
The VWD dog colony has been maintained in Chapel Hill for many years. Although the
bleeding disorder in these dogs has been established as type 3 VWD, the molecular defect
causing the disease had not been determined.26,28 Since our laboratory had previously
identified the sequence of normal canine VWF, we carried out sequencing of the VWF gene
using genomic DNA obtained from the VWD dog.21 In particular, a segment of genomic
sequence spanning from exon 4 to exon 5 of the VWF gene was amplified by PCR. The
591–base pair (bp) PCR product included bases 228 to 323 in exon 4, the 286-bp intron 4,
and bases 324 to 532 in exon 5. A comparison of the normal and VWD sequence is shown in
Figure 1. Sequencing revealed a single (homozygous) nucleotide deletion (ΔC255) in exon 4
of the VWF propeptide (VWFpp), resulting in a frameshift mutation at amino acid 85 of the
VWF protein. After 34 altered amino acids, the shifted reading frame results in a TAG stop
codon at base 359, leading to premature termination of VWF protein synthesis. This
mutation accounts for the complete absence of VWF in the canine VWD plasma.
Although no VWF is detected in the VWD dog plasma, we questioned whether any VWF or
VWFpp protein could be detected in the endothelial cells of the VWD dogs. If these
endothelial cells were indeed VWF-null they would provide a valuable tool for studying the
intracellular trafficking of VWF. VWF trafficking and biogenesis of Weibel-Palade bodies
have previously been studied by our laboratory and others using transformed model cell
lines.17,20,21,29-31 A VWF-null, nontransformed endothelial cell has not been available. We
isolated and characterized the AECs from normal dogs to compare with those obtained from
the VWD dogs. Harvested cells were grown on gelatin, immunostained as described in
“Materials and methods,” and examined by confocal microscopy. Immunostaining for the
endothelial cell marker PECAM-1 (CD31) as shown in Figure 2A demonstrated that a
homogeneous population of normal AECs had been cultured. Immunostaining with a VWF
polyclonal antibody confirmed that the normal canine endothelial cells also express VWF
(Figure 2B). Immunostaining for VWFpp and VWF demonstrated colocalization of VWF
with VWFpp in granules (Figure 2D-F), similar to the Weibel-Palade body distribution in
human umbilical vein endothelial cells (HUVECs).6 Weibel-Palade bodies contain the
membrane protein P-selectin.32,33 Dual-label immunostaining of canine AECs revealed that
endogenous P-selectin was present in the granules containing VWF (Figure 2G-I). These
data confirm that normal canine AECs contain characteristic Weibel-Palade bodies and are
similar to human endothelial cells.
We next harvested and cultured endothelial cells from the VWD dogs. Immunostaining for
PECAM-1 demonstrated a homogeneous population of VWD-AECs has been cultured
(Figure 2J). We could not identify a significant difference in morphology between normal
and VWD endothelial cells. We also stained for VWF, using the polyclonal antibody that
detected the canine VWF in the normal endothelial cells, and no VWF was detected (Figure
2 K, N). No VWF was detected using monoclonal antibodies specific for canine VWF (data
not shown). Although sequencing data predicted the potential synthesis of the first 85 amino
acids of propeptide, we could not detect VWF mRNA by reverse transcriptase (RT)–PCR
using canine specific probes (data not shown). The canine VWD-AECs were immunostained
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by using a mix of several monoclonal antibodies that recognize canine VWFpp, and no
VWFpp expression was detected (Figure 2M). A monoclonal antibody specific for canine
VWFpp also failed to detect VWFpp expression (Figure 2Q). These findings demonstrate
that the AECs obtained from VWD dogs are VWF and VWFpp null at both a protein and an
mRNA level.
Having established the absence of both VWFpp and VWF in the canine VWD-AECs, we
examined the intracellular localization of P-selectin, a recognized marker of the Weibel-
Palade body. The staining of P-selectin was faint and fairly diffuse. Although several very
small granules were observed, most likely these were endosomes/lysosomes (Figure 2P).
This would be consistent with previous findings that in the absence of VWF, in cells lacking
a regulated secretory pathway, P-selectin is delivered to the lysosome and degraded.34 No
apparent Weibel-Palade bodies are detected in the canine VWD-AECs.
The VWF-null canine AECs provide a unique opportunity to study Weibel-Palade body
biogenesis in a naturally occurring animal model of type 3 VWD. We tested the hypothesis
that formation of Weibel-Palade bodies would be induced by expression of either wild-type
human or canine VWF. Full-length VWF constructs were introduced by nucleofection of the
canine VWD-AECs. Transfected cells were immunostained for VWFpp and VWF and
examined by confocal microscopy. In cells expressing canine VWF (data not shown) or
human VWF (Figure 3A-C), both VWFpp and VWF appeared to be colocalized in granules.
In model cell lines, the recruitment of P-selectin to VWF-containing granules has been used
to authenticate the formation of Weibel-Palade bodies.30,31 To confirm the formation of
Weibel-Palade bodies we examined whether VWF-containing granules in nucleofected
canine VWD-AECs would recruit endogenous P-selectin. In cells expressing full-length
human VWF (data not shown) or canine VWF (Figure 3D-F), endogenous P-selectin
colocalized with the VWF in granules, similar to that in the normal canine endothelial cell.
These data indicate that the canine VWD-AECs will support the formation of Weibel-Palade
bodies when VWF is expressed and the Weibel-Palade body distribution of P-selectin is
reestablished.
Previous work in our laboratory demonstrated that the granular storage of VWF in the
AtT-20 model cell line was not dependent on multimerization of VWF.21 To confirm this in
an endothelial cell, we expressed 2 dimeric VWF proteins. The first protein is propeptide-
deleted VWF (Δpro) that contains signal peptide followed directly by the mature VWF
sequence. When canine Δpro (not shown) or human Δpro (Figure 3G-I) were expressed in
the canine VWD-AECs, only diffuse VWF staining was observed, no apparent VWF-
containing granules could be detected. The P-selectin distribution remained diffuse with the
presence of some small granules (Figure 3H) and did not colocalize with VWF (Figure 3I).
The second dimeric VWF protein we expressed is a full-length, propeptide-containing
mutant with a point mutation in the D1 domain of the propeptide (Y87S) that our laboratory
had previously characterized.27 Canine VWD-AECs expressing the Y87S-VWF
demonstrated the presence of VWFpp and VWF colocalized in granules (Figure 3J-L), with
some diffuse staining consistent with localization in the endoplasmic reticulum.
Additionally, P-selectin was recruited to the granules in those cells that were expressing
Y87S-VWF (not shown) verifying that multimerization is not required for granule
formation.
To confirm that the propeptide is required for granule formation, we coexpressed Δpro
together with VWFpp as 2 separate constructs (in trans). We observed that nucleofected
cells received and expressed both Δpro and VWFpp rather than one or the other plasmid (not
shown). Cells expressing both human VWFpp and Δpro proteins displayed the presence of
VWF (and presumably VWFpp) in granules that recruited endogenous P-selectin (Figure
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3M-O). These data indicate that only when Δpro is coexpressed with VWFpp, in either cis or
trans, can granules be formed that recruit endogenous P-selectin. Together, these data
confirm earlier findings that propeptide is necessary for granule formation, Δpro alone is not
sufficient for formation of a Weibel-Palade body, and multimerization of the VWF is not
required for granule biogenesis.
To assess the multimerization of expressed VWF proteins, we analyzed the culture
supernatants of transfected cells by SDS–agarose electrophoresis and Western blotting
(Figure 4A). No VWF multimers were detected in the supernatants of mock-transfected
(lane 7) canine VWD-AECs. Both the wild-type canine and human full-length VWF were
normally multimerized (lanes 2, 3). The lack of VWF multimerization of the Y87S-VWF
and Δpro proteins was confirmed (lanes 4, 5). The conditioned media were also analyzed on
submarine MetaPhor-agarose gels that better define lower molecular weight VWF proteins
(Figure 4B). Both Y87S-VWF and Δpro proteins formed only a dimeric VWF species (lanes
4, 5). Examination of full-length human and canine VWF samples revealed that a higher
molecular weight species (tetramer) migrated into the gel in addition to the VWF dimer
(lanes 1, 3). Densitometry revealed a similar percentage of VWF dimer and tetramer in
human and canine samples (lanes 1, 3; peaks 1, 2). Expression of wild-type VWF proteins in
canine VWD-AECs results in normal multimerization and secretion of VWF.
The propeptide is clearly necessary for formation of a VWF-containing Weibel-Palade body.
Our previous studies in AtT-20 cells demonstrated that VWFpp independently traffics to
ACTH-containing regulated secretory granules, but these studies could not address whether
VWFpp could generate the granule. We exploited the absence of endogenous secretory
granules in the canine VWD-AECs to examine whether the VWF propeptide is sufficient for
Weibel-Palade body formation. Immunostaining and confocal microscopy of cells
expressing either human VWFpp (Figure 5A-C) or canine VWFpp (Figure 5D-F)
demonstrated mostly diffuse staining, although a number of small, VWFpp-containing
granules were occasionally observed. We also examined the distribution of P-selectin in the
VWFpp-expressing canine VWD-AECs. When either human VWFpp (Figure 5G-I) or
canine VWFpp (data not shown) were expressed, the distribution of P-selectin was not
altered. VWFpp and P-selectin did not appear to be colocalized, indicating that VWFpp
alone is not sufficient for formation of a Weibel-Palade body that recruits endogenous P-
selectin. These data suggest that in addition to VWFpp, the mature portion is necessary for
the biogenesis of a P-selectin containing Weibel-Palade body.
We hypothesized that the mature portion of the VWF molecule was providing the dense core
of protein needed for condensation, aggregation, and granule formation. We sought to
determine whether another protein could provide the necessary aggregation. We reported a
VWFpp fusion protein, VWFpp*C3α, that contains signal peptide and VWFpp with a
disrupted furin cleavage site followed by the α-chain of complement C3.19 This
VWFpp*C3α fusion protein is stored in granules in the AtT-20 cell line and sorts to
endogenous, VWF-containing granules in bovine aortic endothelial cells. Due to the
presence of endogenous secretory vesicles in these cells we could not address the biogenesis
of secretory vesicles. Dual-immunostaining for VWFpp and C3α of VWD-AEC expressing
VWFpp*C3α (Figure 5J-L) occasionally showed the presence of a few VWFpp and C3α–
containing granules, although the distribution of VWFpp and C3α in most cells was diffuse.
VWFpp*C3α-transfected cells were also dual labeled for P-selectin and VWFpp. Some
transfected cells demonstrated the presence of VWFpp-containing granules; however, the
VWFpp did not appear to colocalize with endogenous P-selectin (Figure 5M-O). While the
C3α fused to VWFpp may be sufficient for aggregation and granule formation, these
granules do not recruit P-selectin, indicating that the mature portion of VWF may be
necessary for the recruitment of P-selectin to the Weibel-Palade body.
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To determine whether the granules formed by expression of VWF proteins are regulated
secretory granules, we examined whether release of the expressed proteins could be induced
by exposure to the secretagogue, PMA. Confluent transfected cells were exposed to either
PMA or control for 45 minutes at 37°C. The incubation media was collected, and the
amount of VWF (Figure 6A) or VWFpp (Figure 6B) was determined by ELISA. We
observed a significant increase in VWF secretion in response to PMA (429% of control).
The release of Y87S-VWF was also significantly increased (426% of control). Expressed
Δpro did not appear to be released in response to PMA (123% of control). The VWF
expression levels of cells exposed to control were equivalent (Figure 6A). Additionally, the
VWF expression levels over the 24-hour period prior to agonist stimulation were found to be
similar for wild-type VWF, Y87S-VWF, and Δpro, ranging from 3 to 6 mU/mL. The
VWFpp concentration for wild-type VWF and Y87S-VWF samples were also in this range,
indicating a VWFpp/VWF ratio of approximately 1:1. In contrast to full-length VWF, we
did not observe a significant increase in secretion of VWFpp (99% of control) or
VWFpp*C3α (100% of control) in response to PMA (Figure 6B). The prestimulation
expression level of VWFpp*C3α was decreased when compared with VWFpp, 5 mU/mL
and 13 mU/mL, respectively. Cells expressing both VWFpp and Δpro were responsive to
PMA stimulation, and a significant increase in VWFpp secretion (and presumably VWF)
was observed (Figure 6, 729% of control). In this case, the prestimulation expression levels
of VWFpp and Δpro were not proportional. VWFpp concentration was almost 3 times
greater than Δpro, 10 mU/mL and 3 mU/mL, respectively. This disproportionate expression
could account for the seemingly increased agonist-induced release of VWFpp when it is
coexpressed with Δpro. Together, these data indicate that full-length VWF, Y87S-VWF, and
the trans expression of VWFpp and Δpro result in formation of Weibel-Palade bodies that
undergo agonist-induced exocytosis, while Δpro, VWFpp, or VWFpp*C3α are not
trafficked to the regulated storage pathway.
Discussion
In this study, we have identified the molecular defect causing the type 3 VWD in the dogs
from the closed colony maintained in Chapel Hill. The ΔC255 deletion in exon 4 in the
codon corresponding to serine 85 of the VWF propeptide results in 34 amino acids of altered
protein sequence and premature termination of VWF synthesis. This mutation accounts for
the absence of VWF protein in the plasma of the VWD dogs. Interestingly, this is the same
mutation that was identified in Scottish Terriers with type 3 VWD.35 Although the sequence
predicts the synthesis of the first 85 amino acids of VWFpp followed by 34 altered amino
acids, we could not detect any truncated VWFpp protein, nor did we detect VWF mRNA in
the VWD aortic endothelial cells by RT-PCR using canine VWFpp specific primers.
Together these data indicate that the VWD dogs do not synthesize any VWF.
We have confirmed the absence of VWFpp and VWF in the AECs obtained from the VWD
dogs. Examination of the distribution of P-selectin in the VWF-null aortic endothelial cells
verified the absence of recognizable Weibel-Palade bodies in contrast with normal canine
AECs. The canine P-selectin appeared to be degraded rapidly as indicated by the faint,
diffuse staining and localization in small granules presumed to be lysosomes, similar to the
P-selectin distribution observed in the VWF-deficient knockout mouse.25,36 A similar
degradation of P-selectin was demonstrated in the T24 human epithelial cell line that does
not synthesize VWF.29 We were unable to definitively identify the P-selectin–containing
granules as lysosomes due to lack of availability of antibodies cross-reacting with canine
lysosomal proteins. However, the degradation of P-selectin in the absence of a regulated
secretory pathway is well-defined as previously described.34,37,38
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Many prior studies on VWF trafficking have been performed in transformed, non–
endothelial cell lines. Several laboratories have demonstrated the colocalization of P-selectin
with VWF in storage granules when VWF is coexpressed with P-selectin in non–endothelial
cell lines.30,31 A VWF-null, nontransformed endothelial cell has not been available for
exploring the intracellular processing and trafficking of VWF in its natural site of synthesis.
We have developed a system to examine the formation of storage granules in a true
endothelial cell that does not contain preexisting secretory vesicles, synthesizes P-selectin,
and is responsive to secretagogue. Our results using the VWF-null endothelial cells
corroborate many earlier findings. Our laboratory and other investigators have shown that
multimerization and storage of VWF are unlinked, independent processes.17,21,27,30 The
formation of Weibel-Palade bodies that recruit endogenous P-selectin when dimeric Y87S-
VWF is expressed in the canine VWD-AECs provides further evidence. The trans
expression and granular storage of VWFpp and Δpro has been demonstrated in both AtT-20
and CV-1 cell lines.39 In the canine VWD cells, the coexpression of VWFpp and Δpro of
either canine or human origin created Weibel-Palade bodies that recruited endogenous P-
selectin and were released in response to PMA.
The question that has not been addressed in any prior studies is whether the VWFpp alone is
sufficient for the formation of a Weibel-Palade body. Due to the presence of endogenous-
regulated secretory vesicles in AtT-20 and bovine aortic endothelial cells, granule
biogenesis could not be addressed. While the propeptide clearly sorts independently to these
endogenous secretory granules, the ability to generate the storage granule is a different
question. Here we demonstrate that VWFpp alone does not appear to generate a bona fide
Weibel-Palade body. Canine VWD-AECs expressing VWFpp showed mostly diffuse
staining consistent with its localization in the endoplasmic reticulum. Although many small
granules were occasionally observed, the nature of these granules is not clear. The lack of P-
selectin recruitment, diminished size, and lack of agonist-induced release of the granules
formed by VWFpp in the VWF-null endothelial cells indicate that Weibel-Palade bodies are
not formed. While VWFpp is clearly required in addition to mature VWF (Δpro), VWFpp
independently is not sufficient for Weibel-Palade body biogenesis.
Two hypotheses have been proposed that would explain the formation of storage
vesicles.40,41 One hypothesis focuses on the selective aggregation or condensation of
proteins in the trans-Golgi to trigger granule formation. The second proposes that regulated
secretory proteins contain targeting signals that interact with sorting “receptors” that escort
the proteins into the storage pathway. We considered whether the “mature” portion (Δpro) of
VWF is providing the aggregation needed for protein condensation and granule budding, or
whether an alternative protein could substitute for Δpro. In a previous study we fused the α-
chain of complement C3 (C3α) to VWFpp to demonstrate the ability of VWFpp to traffic an
unrelated, non–secretory-granule protein to the regulated storage pathway, but could not
address the biogenesis of the granule.19 In the VWF-null canine endothelial cells, we
observed a subset of cells that contained distinct granules, in addition to a significant
number of cells with diffuse staining consistent with endoplasmic reticulum localization of
VWFpp*C3α. In the cells that showed granule formation, canine P-selectin did not appear to
colocalize with the VWFpp*C3α-containing granules. The lack of P-selectin recruitment
can be rationalized by 1 of 2 explanations. The first explanation is that the VWFpp*C3α-
containing granules are not regulated secretory vesicles. We did not observe any agonist-
induced release of VWFpp*C3α. However, only a small percentage of cells expressing
VWFpp*C3α contained granules, and the amount of released protein may not be within
limits of detection. An alternative explanation for the lack of P-selectin recruitment is that P-
selectin may be brought to the Weibel-Palade body in a VWF-dependent manner. Prior
studies support this hypothesis as P-selectin can be diverted from ACTH-containing
granules in AtT-20 cells (when expressed in the absence of VWF) to granules induced by
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VWF expression that do not contain ACTH.31 The mechanism for this VWF-dependent
recruitment of P-selectin to the Weibel-Palade body remains to be clarified.
Although VWFpp alone does not appear to induce the formation of a Weibel-Palade body, it
is clearly indispensable in the processing and intracellular trafficking of VWF. Evidently,
both VWFpp and mature VWF protein are required for creation of the regulated secretory
vesicle to which P-selectin ultimately traffics. Whether VWFpp provides the “sorting
signal” and mature VWF provides the core of aggregation remains unresolved. With the
exception of type 3 VWD, there have been no reports of patients that lack Weibel-Palade
bodies. In the VWF-deficient mouse, the loss of Weibel-Palade body localized P-selectin
resulted in defective regulated secretion and loss of leukocyte recruitment. Recently, P-
selectin has been shown to interact with endothelial-released ultra-large VWF (ULVWF)
multimers.42 P-selectin may serve to tether the ULVWF to endothelial cells. In addition to
the impact on P-selectin, the loss of Weibel-Palade bodies due to defective VWF would
have an impact on several other proteins, including tissue-type plasminogen activator (t-PA),
interleukin 8 (IL-8), and potentially factor VIII that can be stored with VWF.43-47 Thus,
defining the complex mechanism of Weibel-Palade body biogenesis has significant biologic
implications.
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Figure 1. A homozygous frameshift mutation results in premature termination of VWF protein
synthesis
Genomic DNA obtained from normal and VWD dogs was sequenced, and the 2 sequences
were compared, including sequence from exon 4, intron 4, and exon 5. The protein sequence
is shown above the corresponding nucleic acid sequence with normal canine sequence
shown in bold font above the VWD canine sequence. A single nucleotide deletion was found
in the VWD canine sequence at base pair 255 as highlighted in the box, resulting in a
frameshift. The altered VWD canine protein sequence is shown in italics. The altered VWD
canine nucleotide sequence results in a stop codon at base pair 359 in exon 5.
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Figure 2. Aortic endothelial cells obtained from a normal dog maintain a normal Weibel-Palade
body distribution of VWFpp, VWF, and P-selectin while canine VWD aortic endothelial cells
neither express VWF nor contain Weibel-Palade bodies
(A-I) Endothelial cells were harvested from the aortas of normal dogs, grown on gelatin-
coated slides, fixed, permeabilized, immunostained, and examined by confocal microscopy
as described in “Materials and methods.” Cells immunostained with a mouse monoclonal
anti-PECAM (A) and a polyclonal anti-VWF (B) demonstrated a homogeneous population
of endothelial cells. Staining with a mixture of several mouse monoclonal anti-VWFpp (D)
and a polyclonal anti-VWF (E) demonstrated the presence of both proteins in granules
where they colocalized (F, colocalization is indicated by yellow pixels). Immunostaining of
the normal endothelial cells with the mouse monoclonal anti-VWF, AVW-1 (G), and rabbit
anti–P-selectin (H) revealed that VWF was colocalized with P-selectin in granules (I). The
aortic endothelial cells from normal dogs maintain characteristic Weibel-Palade bodies. (J-
R) Endothelial cells were harvested from the aortas of type 3 VWD dogs, cultured,
immunostained, and examined by confocal microscopy. Cells were dual-labeled with mouse
monoclonal anti-PECAM (J) and polyclonal anti-VWF (K). The homogeneous population of
endothelial cells was VWF-negative. Neither VWF nor VWFpp could be detected in these
cells by immunostaining with a mix of several mouse monoclonal anti-VWFpp antibodies
(M) and polyclonal anti-VWF (N). Cells were also labeled with a rabbit anti–P-selectin
antibody (P) in addition to the canine-specific monoclonal VWFpp antibody (Q). Staining
for P-selectin was faint and diffuse with many small granules (P). No apparent Weibel-
Palade bodies were detected in the canine VWD aortic endothelial cells.
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Figure 3. Expression of human or canine VWF proteins in canine VWD aortic endothelial cells
(A-F) Wild-type VWF. Canine VWD aortic endothelial cells were transiently transfected
with either human VWF (A-C) or canine VWF (D-F) by nucleofection. Transfected cells
were fixed, immunolabeled, and examined by confocal microscopy as described in
“Materials and methods.” Cells were immunolabeled with a mix of several mouse
monoclonal anti-VWFpp antibodies (A), a rabbit anti-VWF (B), AVW-1 mouse monoclonal
anti-VWF (D), or rabbit anti–P-selectin (E). Immunostaining of cells expressing human
VWF demonstrated a granular distribution of VWFpp and VWF (A-B). Merging the 2
images revealed colocalization of the proteins (C). Dual staining for VWF and P-selectin
revealed that the canine VWF (D-F) colocalized with P-selectin in granules. Expression of
canine VWF reestablishes the Weibel-Palade body distribution of endogenous P-selectin.
(G-L) Dimeric VWF. Cells were transiently transfected with either a dimeric, propeptide-
deleted VWF (Δpro) or dimeric, mutant Y87S-VWF. Cells were immunostained using the
monoclonal anti-VWF, AVW-1 (G), rabbit anti–P-selectin (H), a mix of several mouse
monoclonal anti-VWFpp antibodies (J) or polyclonal anti-VWF (K). Cells expressing
human Δpro (G-I) showed diffuse VWF staining with no apparent VWF-containing granules
(G). P-selectin distribution was unchanged (H), and the 2 proteins did not appear to
colocalize (I). A dimeric, Y87S-VWF mutant was also transiently expressed in the canine
VWD aortic endothelial cells (J-L). The mutant Y87S VWFpp and VWF showed a granular
staining pattern in addition to diffuse staining and were found to colocalize (J-L). VWF
multimerization is not necessary for Weibel-Palade body formation. (M-O) Coexpression of
VWFpp and Δpro. Cells were transiently transfected with Δpro and VWFpp in trans as 2
separate constructs. Cells were immunostained using AVW-1 monoclonal anti-VWF (M)
and rabbit anti–P-selectin (N). In cells expressing VWF, P-selectin was found to colocalize
with VWF in granules (O). Coexpression of VWFpp and Δpro generates Weibel-Palade
bodies in canine VWD aortic endothelial cells.
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Figure 4. Multimeric structure of expressed canine and human VWF proteins
(A) The multimeric structure of expressed VWF constructs was analyzed nonreduced on a
3% agarose–SDS gel. All samples were run on the same gel, and interfering (nonrelevant)
lanes have been removed for clarity. No VWF was detected in the mock-transfected control
(lane 7). Wild-type canine and human full-length VWF (lanes 2, 3) and normal human and
canine plasmas (lanes 1 and 6) were normally multimerized. Neither Y87S-VWF (lane 4)
nor Δpro (propeptide-deleted VWF, lane 5) formed high molecular weight multimers. (B)
The structure of lower molecular weight VWF subunits was analyzed on a 3% MetaPhor-
agarose submarine gel. No VWF was detected in the mock-transfected control (lane 2).
Y87S-VWF and Δpro formed only a dimeric VWF species (lanes 4, 5). The density of the
dimer and tetramer bands observed in human and canine VWF (lanes 1, 3) were calculated
after scanning the immunoblot (peak 1 = dimer).
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Figure 5. VWFpp alone does not induce Weibel-Palade body formation
The VWFpp and the fusion protein VWFpp*C3α were independently expressed in canine
VWD aortic endothelial cells. Transfected cells were processed and examined as described
in “Materials and methods.” Cells were immunostained with a rabbit anti-VWFpp (A, D), a
mix of several monoclonal anti-VWFpp antibodies (G, J, M), mouse anti-PECAM (B, E),
rabbit–anti-P-selectin (H, N), or polyclonal anti-C3 antibody (K). In cells expressing either
human VWFpp (A-C) or canine VWFpp (D-F), the distribution of VWFpp was diffuse,
although small VWFpp-containing granules were occasionally observed (D). Cells
expressing human VWFpp were dual stained for VWFpp (G) and P-selectin (H): P-selectin
distribution was unchanged compared with untransfected VWD endothelial cells and very
little colocalization of VWFpp and P-selectin was observed (I). Cells expressing the
VWFpp*C3α fusion protein showed both diffuse staining as well as granular storage of both
VWFpp (J) and C3α (K). Dual-staining for VWFpp (M) and P-selectin (N) revealed very
little colocalization of the VWFpp*C3α protein with P-selectin (O). While the VWFpp*C3α
protein may induce granule formation in the canine VWD aortic endothelial cells, P-selectin
is not recruited to the newly formed granule.
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Figure 6. Agonist-induced release of expressed VWF proteins from canine VWD aortic
endothelial cells
Canine VWD aortic endothelial cells were transiently transfected with Δpro, wild-type
VWF, Y87S-VWF, VWFpp, VWFpp*C3α, or VWFpp +Δpro (trans). The culture media
were harvested from transfected cells, the cells washed with HBSS, then cells were
incubated with either 2 μM PMA or OptiMEM (control) for 45 minutes. The incubation
media were collected, and the amount of VWF or VWFpp was quantitated by ELISA. (A)
The concentration of released Δpro, wild-type VWF, and Y87S-VWF was determined by
VWF ELISA. (Legend: /C = control and /P = PMA treated) (B) The concentration of
released VWFpp, VWFpp*C3α, and VWFpp + Δpro (trans) were determined by VWFpp
ELISA. Wild-type VWF, Y87S-VWF, and VWFpp + Δpro (trans) were released in response
to PMA, while Δpro, VWFpp, and VWFpp*C3α did not show a significant increase in
protein release.
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